Clinical Trials Browser

Phase 1/2 × Imiquimod × Lymphoid × Clear all

NCT03559413 2023-12-04

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma